Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 genetic diversity: Its impact on vaccine efficacy.

Infectious diseases now - 1 Nov 2022

Lina B, Bauer J

Abstract excerpt

SARS CoV 2 S-glycoproteins play a crucial role in the entry steps of viral particles. Due to their surface location, they are the main target for host immune responses and the focus of most vaccine strategies. The D614G mutation identified in late January became dominant during March 2020, rendering SARS-CoV-2 more infectious. In April 2020, the Alpha, Beta and Gamma variants emerged simultaneously in Asia, South...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to COVID-19
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neutralization Tests

Share to RNA, Messenger

Share to RNA, Viral

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 36108974
DOI: 10.1016/j.idnow.2022.09.008
PMCID: PMC9467922

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 genetic diversity: Its impact on vaccine efficacy.PMID 36108974Read ↗

Emerging SARS-CoV-2 variants: Why, how, and what's next?Semantic proximity Read ↗

Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessSemantic proximity Read ↗

Evolution and implications of SARS-CoV-2 variants in the post-pandemic eraSemantic proximity Read ↗

The Variation of SARS-CoV-2 and Advanced Research on Current VaccinesSemantic proximity Read ↗

From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the WorldSemantic proximity Read ↗

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19Semantic proximity Read ↗

Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions.Semantic proximity Read ↗

COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants.Semantic proximity Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Semantic proximity Read ↗

Emerging Omicron Subvariants EG.5 and BA.2.86: Implications for COVID-19 Immunity and SurveillanceSemantic proximity Read ↗

SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.